tiprankstipranks

Adicet Bio price target lowered to $19 from $21 at Canaccord

Canaccord lowered the firm’s price target on Adicet Bio to $19 from $21 and keeps a Buy rating on the shares. The firm noted the company is shifting its focus to autoimmune diseases and lowered its target to reflect a delayed pivotal trial.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on ACET:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue